Evidence map›Paper›PMID 39494820›Full record

ArticleInternational journal of technology assessment in health care2024

Implementing a sandbox approach in health technology assessment: benefits and recommendations.

Jamie Elvidge, Nick Crabb, Diana Delnoij, Saskia Knies, Douglas Lundin, François Houÿez, Juha Röning, Junfeng Wang, Li Jiu, Alastair Bennett and 2 more

Abstract read
In one paragraph

Article in International journal of technology assessment in health care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jamie ElvidgeScience Evidence and Analytics Directorate, National Institute for Health and Care Excellence, UK.ORCID https://orcid.org/0000-0002-6154-8091
Nick CrabbScience Evidence and Analytics Directorate, National Institute for Health and Care Excellence, UK.
Diana DelnoijErasmus School of Health Policy and Management, Erasmus University, The Netherlands.
Saskia KniesNational Health Care Institute, Diemen, Rotterdam, The Netherlands.
Douglas LundinDepartment of the General Director, The Dental and Pharmaceutical Benefits Agency, Stockholm, Sweden.
François HouÿezTreatment Information and Access Department, EURORDIS, Paris, France.
Juha RöningBiomimetics and Intelligent Systems Group, University of Oulu, Oulu, Finland.
Junfeng WangDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.
Li JiuDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.ORCID https://orcid.org/0000-0001-6546-0778
Alastair BennettCentre for Health Economics, University of York, York, UK.
Yingying ZhangCentre for Health Economics, University of York, York, UK.
Dalia DawoudScience Evidence and Analytics Directorate, National Institute for Health and Care Excellence, UK.

Funding

H2020 Health 825162
6 · The paper itself

Abstract

objectivesThe sandbox approach, developed in the financial technologies sector, creates an environment to collaboratively develop and test innovative new products, methods and regulatory approaches, separated from business as usual. It has been used in health care to encourage innovation in response to emerging challenges, but, until recently, has not been used in health technology assessment (HTA). This article summarizes our learnings from using the sandbox approach to address three challenges facing HTA organizations and to identify implications for the use of this approach in HTA.

methodsWe identified three challenging contemporary HTA-related topics to explore in a sandbox environment, away from the pressures and interests of "live" assessments. We convened a pool of 120 stakeholders and experts to participate in various sandbox activities and ultimately co-develop solutions to help HTA organizations respond to the identified challenges.

resultsImportant general learnings about the potential benefits and implementation of a sandbox approach in HTA were identified. Consequently, we developed recommendations to guide its use, including how to implement an HTA sandbox in an effective way and the types of challenges for which it may be best suited.

conclusionsFor many HTA organizations, it is difficult to carefully consider emerging challenges and innovate their processes due to risks associated with decision errors and resource limitations. The sandbox approach could reduce these barriers. The potential benefits of addressing HTA challenges in a collaborative "safe space" are considerable.

Indexed as

Technology Assessment, BiomedicalCooperative BehaviorDecision MakingHumansStakeholder Participationhealth technology assessmentHTAinnovationpolicy sandboxsandbox

Identifiers

PMID39494820
PMCPMC11569896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.